US Patent Issued to Jiangsu Hengrui Medicine, SHANGHAI HENGRUI PHARMACEUTICAL on June 30 for "Method for treating autoimmune disease by IL-17 antagonist" (Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,625, issued on June 30, was assigned to Jiangsu Hengrui Medicine Co. Ltd. (Lianyungang, China) and SHANGHAI HENGRUI PHARMACEUTICAL Co. LTD. (Shanghai).

"Method for treating autoimmune disease by IL-17 antagonist" was invented by Piaoyang Sun (Lianyungang, China), Lianshan Zhang (Lianyungang, China), Jianwen Chen (Lianyungang, China), Qian Xu (Lianyungang, China) and Qunjie Gao (Lianyungang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to a method for treating an autoimmune disease by an IL-17 antagonist. The present application relates to an application of an IL-17A binding agent in preparation of a drug for t...